Market Movers (8-K)
NYSE
James Hardie Industries plc announced the strategic divestiture of its European operations, including the Fermacell business, to Holcim for approximately $980 million USD, alongside a $250 million share repurchase program.
Delay expected
NYSE
James Hardie Industries plc reported strong first-quarter results for FY27, exceeding original guidance for sales and Adjusted EBITDA, and subsequently raised its full-year FY27 outlook.
Better than expected
NYSE
James Hardie Industries plc has filed its Fiscal Year 2026 Irish Statutory Accounts, detailing financial performance and operational updates.
Worse than expected
NYSE
James Hardie reported strong Q4 FY26 results with a 45% increase in net sales, exceeding guidance, and provided a positive outlook for FY27 with expected Adjusted EBITDA growth.
Quarterly Earnings (10-Q)
NYSE
James Hardie Industries plc announced a significant 64% increase in net sales for the first quarter of fiscal year 2027, largely attributed to the successful integration of The AZEK Company Inc.
Better than expected
Insider Trading (Form 4)
See all →NYSE
Renee J Peterson, a Director of James Hardie Industries plc, received 743 shares of common stock on September 15, 2026.
NYSE
Gary E Hendrickson, a Director of James Hardie Industries plc, received 1,140 shares of common stock on September 15, 2026.
NYSE
Suzanne B Rowland, a Director of James Hardie Industries plc, received 748 shares of common stock on September 15, 2026.
NYSE
Nigel Stein, a Director of James Hardie Industries plc, received 903 shares of common stock on September 15, 2026.
NYSE
Jesse G Singh, a Director of James Hardie Industries plc, received 744 shares of common stock on September 15, 2026.
NYSE
Howard C Heckes, a Director of James Hardie Industries plc, received 1,268 shares of common stock on September 15, 2026.
Proxy Statements (Def-14A)
NYSE
James Hardie Industries plc has announced its 2026 Annual General Meeting (AGM) to be held on August 20, 2026, where shareholders will vote on director re-elections, executive compensation, and proposed amendments to the company's Articles of Association.
Schedule 13G - Passive Investments
See all →NYSE
Wellington Management Group LLP and its affiliates have filed an amendment to their Schedule 13G, reporting beneficial ownership of 8.0% of James Hardie Industries plc's common stock as of June 30, 2026.
NYSE
FMR LLC, along with Abigail P. Johnson, has reported a beneficial ownership of 7.0% of James Hardie Industries PLC's common stock as of June 30, 2026.
NYSE
FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 5.9% in James Hardie Industries PLC as of March 31, 2026.
NYSE
Vanguard Capital Management has reported beneficial ownership of 5% of James Hardie Industries PLC's common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in James Hardie Industries PLC following an internal corporate realignment.
NYSE
BlackRock, Inc. has filed an Amendment No. 7 to its Schedule 13G, disclosing a 1.2% beneficial ownership in James Hardie Industries PLC as of December 31, 2025.